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ttp://dx.doi.org/10.1016/j.ajpath.2013.05.029First trimester human decidua is composed of decidual cells, CD56brightCD16 decidual natural killer
(dNK) cells, and macrophages. Decidual cells incubated with NK cellederived IFN-g and either
macrophage-derived TNF-a or IL-1b synergistically enhanced mRNA and protein expression of IP-10 and
I-TAC. Both chemokines recruit CXCR3-expressing NK cells. This synergy required IFN-g receptor 1 and 2
mediation via JAK/STAT and NFkB signaling pathways. However, synergy was not observed on
neutrophil, monocyte, and NK cellerecruiting chemokines. Immunostaining of ﬁrst trimester decidua
localized IP-10, I-TAC, IFN-gR1, and -R2 to vimentin-positive decidual cells versus cytokeratin-positive
interstitial trophoblasts. Flow cytometry identiﬁed high CXCR3 levels on dNK cells and minority
peripheral CD56brightCD16 pNK cells and intermediate CXCR3 levels on the majority of CD56dimCD16þ
pNK cells. Incubation of pNK cells with either IP-10 or I-TAC elicited concentration-dependent
enhanced CXCR3 levels and migration of both pNK cell subsets that peaked at 10 ng/mL, whereas
each chemokine at a concentration of 50 ng/mL inhibited CXCR3 expression and pNK cell migration.
Deciduae from women with preeclampsia, a leading cause of maternal and fetal morbidity and mortality,
displayed signiﬁcantly lower dNK cell numbers and higher IP-10 and I-TAC levels versus gestational agee
matched controls. Signiﬁcantly elevated IP-10 levels in ﬁrst trimester sera from women eventually
developing preeclampsia compared with controls, identifying IP-10 as a novel, robust early predictor of
preeclampsia. (Am J Pathol 2013, 183: 841e856; http://dx.doi.org/10.1016/j.ajpath.2013.05.029)Supported by NIH grants R01HD33937-12 (C.J.L.), Project 2
PO1HD054713-01A1 (C.J.L.), and R01HD056123-04 (S.J.H.).In normal human pregnancy, blastocyst-derived extravillous
cytotrophoblasts (EVTs) traverse the underlying decidua
and inner third of the myometrium. As they cross the
decidua, EVTs detach from anchoring placental villous
columns, then breech spiral arteries and arterioles to mediate
replacement of the smooth muscle tunica media and endo-
thelium. This invasive process can occur either from the
vessel lumen into the tunica media, mediated by endovas-
cular EVTs, or from the surrounding decidualized stroma
into the tunica media, mediated by interstitial EVTs. On
entering the vessel, the epithelial cell adhesion moleculestigative Pathology.
.phenotype of trophoblasts is converted to an endothelial
cellelike adhesion molecule phenotype,1 and spiral vessels
are transformed into low-resistance, high-capacity conduits
that increase uteroplacental blood ﬂow to the developing
fetaleplacental unit.1,2
Preeclampsia, a major cause of maternal and perinatal
morbidity and mortality,3 is frequently associated with
shallow trophoblast invasion leading to incomplete uterine
Lockwood et alvascular remodeling.4 The resulting decreased uteropla-
cental blood ﬂow can elicit fetal growth restriction and/or
elaboration of antiangiogenic and proinﬂammatory placental
factors that mediate the maternal syndrome of hypertension
and proteinuria, which usually occurs later in pregnancy and
can produce end-organ damage.5
At the human implantation site, the decidua is composed
primarily of resident decidual cells (50%) and a diverse
immune cell population (40%). The latter is dominated by
decidual natural killer (dNK) cells (70%), macrophages
(20%), and T lymphocytes (10%) with small percentages of
dendritic cells and B lymphocytes.6 Unlike the major
antigen-presenting cells, macrophages and dendritic cells,
NK cells act as specialized lymphocytes and normally
mediate innate immunity by killing tumor and virus-infected
cells without prior sensitization before the onset of T- and
B-cellemediated adaptive immunity. In the circulation, NK
cells comprise approximately 5% to 15% of the lymphocyte
population and consist primarily of two functionally distinct
subsets. The majority, CD56dimCD16þ peripheral NK
(pNK) cells (90%), exhibit greater cytotoxicity, express high
levels of killer cell immunoglobulin-like receptors (KIRs),
as well as CD57, and usually do not secrete cytokines. By
contrast, the absence of CD16 expression by the minority,
less mature, CD56brightCD16 pNK cells (10%), accounts
for their inability to mediate antibody-dependent cell
toxicity.7 These CD56brightCD16 pNK cells do not display
KIRs, but express low levels of perforin and high levels of
the CD94/NKG2 receptor and adhesion-mediating L-selectin.8
They also serve as the major pNK cell source of secreted
immunoregulatory cytokines. Chief among these is
interferon-gamma (IFN-g). This prototypic NK cell cyto-
kine is expressed by CD56brightCD16 pNK cells in
response to IL-12 acting in concert with either other cyto-
kines (ie, IL-1, IL-2, IL-15, or IL-18) or engagement of
either the CD16 (FcgRIIIa) or NKG2D pNK cell-activating
receptors.9 Recently, the microRNA (miR155) was also
shown to function as a positive regulator of IFN-g expres-
sion in pNK cells.10 Other immunoregulatory cytokines
expressed by CD56brightCD16 pNK cells include tumor
necrosis factor-b (TNF-b), granulocyte-macrophage colony
stimulating factor (GM-CSF), and IL-10 and -13.7
Like the minority circulating NK cell population,
approximately 80% of dNK cells are also CD56bright
CD16.7,11 Extensive investigation indicates that dNK cells
represent a unique immune cell subtype that plays a crucial
pregnancy-supporting role by fostering immune tolerance of
the semiallogeneic fetaleplacental unit while promoting
EVT invasion and spiral artery and arteriole remodeling via
expression of vascular endothelial and placental growth
factors.7,11e13
The current study postulates that at the human implan-
tation site, targeting of the majority resident decidual cells
by paracrine effectors, secreted primarily by dNK cells and
macrophages, recruits additional CD56brightCD16 pNK
cells into the decidua. In support of this hypothesis, ﬂow842cytometric analysis singled out high CXCR3 expression by
CD56brightCD16 dNK cells and CD56brightCD16 pNK
cells, and lower expression by CD56dimCD16þ pNK cells.
Complementing these observations, mRNA and protein
expression of IFN-geinduced protein 10 (IP-10/CXCL10)
and IFN-inducible T cellea chemoattractant (I-TAC/
CXCL11), chemokines that speciﬁcally recruit CXCR3-
bearing pNK cells,14 proved to be synergistically en-
hanced during incubation of human leukocyte-free ﬁrst
trimester decidual cells with the primary NK cellederived
cytokine, IFN-g,12 and either of the primary macrophage-
derived cytokines, TNF-a or IL-1b.15 These observations
were augmented by: i) evaluating the potential involvement
of both IFN-g receptors (IFN-gR1 and IFN-gR2),16 as well
as signaling pathways in mediating this synergistic up-
regulation of IP-10 and I-TAC in decidual cells; ii) func-
tional studies that assessed the individual and combined
effects of IP-10 and I-TAC on CXCR3 expression and
migration of both subsets of pNK cells; iii) in situ studies
that assessed cellular localization of IP-10, I-TAC, and IFN-
gR1 and -R2 at the human implantation site and compared
IP-10 and I-TAC levels and the abundance of CD56bright
CD16 NK cells in preeclamptic versus gestational agee
matched control decidua; and iv) measurement of IP-10 and
I-TAC levels in ﬁrst trimester sera to determine whether
either chemokine is an early predictor of preeclampsia.
Materials and Methods
Tissues and Blood Samples
Decidual samples obtained from patients undergoing
termination of pregnancy (6 to 12 weeks gestation) at the
New York University Medical Center and Yale-New Haven
Hospital, under New York University Institutional Review
Board and Yale Human Investigative Committee approval,
were used to isolate decidual cells and for ﬂow cytometric
analysis of dNK cells. Decidual samples (6 to 12 weeks and
37 to 40 weeks) were also obtained under institutional
review board approval at the Mackay Memorial Hospital in
Taiwan and used for immunostaining and tissue enzyme-
linked immunosorbent assays (ELISAs). Peripheral blood
samples from volunteers were obtained from the Harvard
Department of Molecular and Cellular Biology for use in
ﬂow cytometric analysis, and from the Yale-New Haven
Hospital for use in measuring CXCR3 expression by NK
cells, as well as their migration in a Transwell assay, under
institutional review board and human investigative com-
mittee approval, respectively.
Isolation of Decidual Cells and NK Cells
Decidual tissues derived from ﬁrst trimester elective termi-
nations were washed in sterile PBS until clear of blood,
minced, and then digested with 0.1% collagenase type IV
and 0.01% DNase (Sigma-Aldrich, St. Louis, MO) in RPMIajp.amjpathol.org - The American Journal of Pathology
Decidual Cells Recruit Decidual NK Cells1640 containing 20 mg/mL penicillin/streptomycin, 1 mL/mL
fungizone (Invitrogen, Carlsbad, CA) in a 37C shaking
water bath for 30 minutes followed by washing with PBS.
The digestate was subjected to consecutive ﬁltration through
100-mm, 70-mm, and 40-mm Millipore ﬁlters (Millipore,
Billerica, MA). The resulting pellet was resuspended in
complete RPMI (Invitrogen), then seeded onto six 10-cm
Petri dishes and incubated at 37C in a humidiﬁed 95%
O2:5% CO2 incubator for 2 hours to enrich for decidual cells
(plastic adherent) and lymphocytes (nonadherent). The
leukocyte-enriched supernatants were washed with complete
RPMI and cell pellets resuspended in complete RPMI,
layered over Ficoll-Hypaque (Pharmacia and Upjohn, Chi-
cago, IL), and centrifuged for 20 minutes at 509  g. The
decidual leukocyte band at the interface was washed twice
with PBS plus 2% fetal calf serum, and then subjected to ﬂow
cytometric analysis (see below).
Adherent decidual cells were detached with 0.1% trypsin-
EDTA (Sigma-Aldrich), resuspended in RPMI, grown to
conﬂuence on polystyrene tissue culture dishes, harvested
using trypsin-EDTA, and analyzed by ﬂow cytometry with
anti-CD45 and anti-CD14 monoclonal antibodies (BD Phar-
mingen, SanDiego, CA) tomonitor the presence of leukocytes
after each passage. After three to four passages, cell cultures
were found to be leukocyte-free (<1%). Conﬂuent decidual
cells were vimentin-positive and cytokeratin-negative, and
displayed progesterone-induced decidualization-related mor-
phological and biochemical changes, including elevated
prolactin and plasminogen activator inhibitor-1 (PAI-1), and
reduced interstitial collagenase and stromelysin-1 expression
(results not shown). Cell aliquots were frozen in fetal calf
serum/dimethyl sulfoxide (9:1 ratio) (Sigma-Aldrich) and
stored in liquid nitrogen.
As previously described, peripheral blood from anony-
mous healthy reproductive-age donors was used to isolate
NK cells using Ficoll followed by enrichment for NK cells
with RosetteSep according to the manufacturer’s instruc-
tions (Stem Cell Technologies, Vancouver, BC, Canada).17
Experimental Incubations
Thawed decidual cells were incubated in basal medium
(BM), a phenol redefree 1:1 v/v mix of Dulbecco’s modiﬁed
Eagle’s medium (Invitrogen) and Ham’s F-12 (Flow Labs,
Rockville, MD), with 100 U/mL penicillin, 100 mg/mL
streptomycin, 0.25 mg/mL fungizone supplemented with
10% charcoal-stripped calf serum (BMS). After two addi-
tional passages, conﬂuent cultures were incubated in
parallel in BMS containing 108 mol/L estradiol (E2) with
107 mol/L medroxyprogesterone acetate (MPA) (Sigma-
Aldrich), which was used in place of progesterone because of
its greater stability in culture.18 After 7 days, the cultures were
washed twice with HBSS to remove residual serum elements
and then switched to a deﬁned medium consisting of BM plus
ITSþ (Collaborative Research, Waltham, MA), 5 mmol/L
FeSO4, 0.5 mmol/L ZnSO4, 1 nmol/L CuSO4, 20 nmol/LThe American Journal of Pathology - ajp.amjpathol.orgNa2SeO3, trace elements (Invitrogen), 50 mg/mL ascorbic
acid (Sigma-Aldrich), and 50 ng/mL epidermal growth factor
(Becton-Dickinson, Bedford, MA) with steroids alone or
with 0.01 to 10 ng/mL IFN-g, IL-1b, TNF-a, or with IFN-g
plus IL-1b or TNF-a (R&D Systems). After the incubation,
cells were harvested by scraping into ice-cold PBS, pelleted,
and extracted in ice-cold lysis buffer. Conditioned medium
supernatants and cell lysates were stored at 70C. Total
RNA was extracted from parallel incubations with Tri
Reagent (Sigma-Aldrich).
Signaling Pathway Mediation of IP-10 and I-TAC
Expression
Conﬂuent ﬁrst trimester decidual cells were pretreated in
deﬁned medium  10 mmol/L NFkB inhibitor BAY-11-
7082 (BAY; EMD Chemical, San Diego, CA), or 100 mmol/L
Janus kinase/signal transducers and activators of transcription
(JAK/STAT) inhibitor 50-deoxy-50-(methylthio)adenosine
(MTA) (EMD Chemical) or BAY þMTA. The cultures were
then incubated with control (vehicle) or TNF-a or IFN-g or
TNF-a þ IFN-g in parallel either for 24 hours and then the
conditioned medium was collected for ELISAs, or for 30
minutes and then subjected to nuclear extraction for ELISA-
based electromobility shift assay (E-EMSA).
E-EMSA
First trimester decidual cells were treated for 30 minutes as
described above, then rinsed in ice-cold PBS containing
a protease inhibitor cocktail, and immediately stored at
80C. A Nuclear Extraction Kit was used according to the
manufacturer’s instruction (Active Motive, Carlsbad, CA).
NFkB transcriptional activity was determined using
a TransAM NFkB transcription factor ELISA kit (Active
Motive) following the manufacturer’s instructions. This kit
measures both p65 and p50 NFkB subunits that bind to 96-
well plates precoated with NFkB DNA response elements
(NFkB-RE). A colorimetric reaction was obtained using
a 96-well plate luminometer at 450 nm and an optional
reference wavelength of 655 nm.
Flow Cytometry
Flow cytometry was performed as described previously.17
Brieﬂy, cell sorting and ﬂuorescence measurements were
carried out on a MoFlo high-performance cell sorter (Cyto-
mation, Fort Collins, CO). For ﬂuorescencemeasurements, the
following mouse anti-human monoclonal antibodies
were obtained from BD Pharmingen: CD16eﬂuorescein
isothiocyanate (IgG1), CD56-phycoerythrin (IgG1), and
CD3-Cyc (IgG1), and from R&D Systems: Phycoerythrin-
conjugated mouse monoclonal anti-human CCR1 (IgG2b),
CCR9 (IgG2a), CXCR1 (IgG2a), CXCR3 (IgG1), CXCR4
(IgG2a), and CCR7 (IgG2a). The CCR7 antibody was
used together with goat anti-mouse IgG-phycoerythrin as843
Lockwood et ala secondary ﬂuorochrome conjugate (Caltag, Burlingame,
CA). All IgG isotype control antibodies were obtained from
BD Biosciences (Los Angeles, CA). For ﬂow cytometric
analysis, cells were incubated with 10% human serum to block
Fc-receptors before incubation with monoclonal antibodies on
ice for 30 minutes, followed by washing twice in PBS with
0.5% bovine serum albumin. Surface expression of chemokine
receptors on pNK and dNK cells was detected with a standard
FACSCalibur ﬂow cytometer (Immunocytometry Systems;
BectonDickinson, San Jose, CA). In thesemeasurements, data
from 10,000 single-cell events were collected and analyzed
using CellQuest version 2.0 (Becton Dickinson) or FlowJo
version 7.6.5 (TreeStar, San Carlos, CA).
ELISA
Total cell protein levels were measured by a modiﬁed
Lowry assay (Bio-Rad Laboratories, Hercules, CA). Com-
mercial ELISA kits measured immunoreactive levels of
IP-10, I-TAC, IL-6, IL-8, IL-11, and monocyte chemotactic
protein (MCP)-1 in decidual celleconditioned medium
supernatants according to the manufacturer’s instructions
(Duoset kits; R&D Systems). The IP-10 and I-TAC ELISAs
have sensitivities of 8 and 2 pg/mL, respectively. The intra-
assay coefﬁcients of variation (COV) for IP-10 and I-TAC
are each <5.0%, and interassay COV are each <10%. The
IL-6 ELISA has a sensitivity of 3 pg/mL; intra-assay and
interassay COV are 3.1% and 2.7%, respectively. The IL-8
ELISA has a sensitivity of 8 pg/mL, and intra-assay and
interassay COV are 4.6% and 6.7%, respectively. The IL-11
ELISA has a sensitivity of 10 pg/mL, and intra-assay and
interassay COV are 2.4% and 6.9%, respectively. The
MCP-1 ELISA has a sensitivity of 4 pg/mL, and intra-assay
and interassay COV are 5.0% and 5.1%, respectively.
Microarray Analysis
Total RNA from decidual cell cultures was extracted as
previously described.19 For microarray studies, cells har-
vested with QIAzol lysis reagent (Qiagen, Valencia, CA)
were used to prepare total RNA, which was cleaned and
precipitated using the RNeasyMini Kit (Qiagen). The quality
of RNA was conﬁrmed by a Bio-Rad bioanalyzer. Array
processing was performed at the W. M. Keck Foundation
Biotechnology Resource Laboratory at Yale University using
HG_U133 Plus 2.0 chips (Affymetrix, Santa Clara, CA). Raw
data without normalization generated from Affymetrix Gen-
eChip Operating Software version 1.2 (GCOS 1.2) (Affy-
metrix) were analyzed by GeneSpring software version 7.2
(Agilent Technologies/SiliconGenetics, RedwoodCity, CA).
Gene readouts were normalized to the 50th percentile of the
distribution of all measurements in each chip. Normalization
for each gene across chips was performed using the median
value of each gene throughout different chips in the same
experimental condition. Normalized data were ﬁltered to
eliminate those genes whose mRNA were found to be absent844in all experimental conditions and replicates. A parametric
test assuming unequal variance was then used to assess
statistical signiﬁcance. Fold-ratios were derived by
comparing normalized data between E2þMPA versus E2þ
MPA þ IL-1b or TNF-a groups with a cutoff of 2-
fold. Microarray results were conﬁrmed by quantitative
RT-PCR.
Quantitative RT-PCR
Total RNA from decidual cell cultures derived from eight
patients was isolated and puriﬁed using a column kit with
DNase treatment (Ambion, Austin, TX). Generation of
cDNA from puriﬁed DNA-free RNA used the SuperScript II
Reverse Transcriptase kit (Invitrogen). qPCR was per-
formed using TaqMan gene expression assays for IP-10,
I-TAC, and the reference gene b-actin (Applied Biosystems,
Foster City, CA). Standard curves were created from serial
dilutions of a known sample for each gene assay. All
samples were run in duplicate and the average used for each
sample. The efﬁciency for each TaqMan gene assay was
>94%. The TaqMan Assay ID#s were: Hs00171042_m1
(for IP-10), Hs00171138_m1 (for I-TAC ), and
Hs99999903_m1 (for b-actin). The relative standard curve
method was used (versus the comparative CT method,
DDCT). For each standard curve, an independent sample
known to contain very high expression of the gene of interest
was used. Serial dilutions were made from this independent
sample and used in the standard curve to calculate the
unknowns according to the manufacturer’s instructions.
Western Blotting
Western blot analysis was performed on conditioned
medium supernatants, diluted 1:6 in reducing Laemmli 6
sample buffer (Boston Bioproducts, Ashland, MA), then
boiled for 5 minutes. Recombinant human IP-10 and I-TAC
proteins (R&D Systems) were treated similarly as positive
controls. Centrifuged conditioned medium supernatants and
positive controls were subjected to SDS-PAGE on 15%
Tris-HCl gels (BioRad) with subsequent electroblotting
transfer onto 0.20-mm nitrocellulose membranes (BioRad).
After transfer, membranes were blocked for 3 hours at room
temperature in Odyssey blocking buffer (LI-COR Biosci-
ences, Lincoln, NE) and then incubated overnight at 4C
with goat antibodies to IP-10 and I-TAC (R&D Systems).
After washing, membranes were incubated in donkey anti-
goat IRDye 680 (LI-COR) at room temperature for 1 hour
and washed again before visualizing with the Odyssey
infrared imaging system (LI-COR).
siRNA Transfection
Transient transfections used a modiﬁed protocol.20 Brieﬂy,
to prepare siRNA/lipid solutions for a 12-well plate scale
transfection, 64 pmol (equivalent of 20 mL of a 3 mmol/Lajp.amjpathol.org - The American Journal of Pathology
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(Invitrogen) and incubated at room temperature for
5 minutes. For IFN-gR1 and IFN-gR2 double knockdown,
32 pmol of each siRNA was combined in a ﬁnal amount of
64 pmol. In a separate tube, 8 mL of Lipofectamine 2000
(Invitrogen) was diluted in 200 mL of OPTI-MEMI and
incubated at room temperature for 5 minutes. The contents
of both tubes were mixed by gentle pipetting and then
incubated at room temperature for 30 to 50 minutes. The
resulting 400-mL solution was used to transfect 2  105 cells
(see below). The siRNAs speciﬁc for IFN-gR1 (siR1)
(ON-TARGETplus SMARTpool L-011057-00-0005) and
IFN-gR2 (siR2) (ON-TARGETplus SMARTpool L-012713-
00-0005), and control nontarget siRNA (D-001810-1005)
were from Thermo Fisher Scientiﬁc/Dharmacon Products
(Lafayette, CO).
To prepare cell pellets for transfection, ﬁrst trimester
leukocyte-free decidual cells grown in BM were dissociated
using 0.25% Trypsin/EDTA (Sigma-Aldrich). Cell pellets
were collected by centrifugation at 700  g for 2 minutes.
Each cell pellet containing about 2  105 cells was gently
resuspended in 400 mL of the siRNA/lipid solution prepared
as described above, and the cell suspension was incubated at
room temperature for 10 minutes (note, incubation for >15
minutes decreases cell viability). At the end of the incuba-
tion, 1.6 mL of BM was added and the resulting cell
suspension transferred to a well of a 12-well plate, followed
by incubation in a CO2 tissue culture incubator overnight.
The medium was replaced on the second day of incubation.
Immunohistochemistry
First and third trimester deciduae were snap-frozen in liquid
nitrogen for 5-mm cryosections. Morphology was conﬁrmed
after H&E staining. Sections were air-dried and ﬁxed in ice-
cold acetone for 10 minutes, then rehydrated with PBS for
5 minutes, subjected to protein block (Dako, Atlanta, GA)
for 20 minutes, and incubated in goat anti-human IP-10
(dilution 1:10; R&D Systems), rabbit anti-human I-TAC, or
mouse anti-human IFN-gR1/R2 (dilution 1:250; Abcam,
Cambridge, MA) antibodies for 1 hour at room temperature.
After 3 washes in PBS, sections were incubated with ﬂuo-
rescein isothiocyanateeconjugated rabbit anti-goat (dilution
1:20; Dako), donkey anti-mouse (dilution 1:50; Millipore),
or donkey anti-rabbit (dilution 1:50; Millipore) antibodies
for 1 hour.
Sections were double stained by washing 3 with PBS
and incubating in either goat anti-human vimentin anti-
body (dilution 1:500; Sigma-Aldrich) or mouse anti-human
vimentin antibody (dilution 1:400; Millipore), mouse anti-
human cytokeratin 7 (CK7) antibody (dilution 1:100; Dako),
goat anti-CD16 antibody (dilution 1:100; R&D Systems), or
mouse anti-CD56antibody (dilution1:100;R&DSystems) for
1 hour at room temperature. After three additional washes in
PBS, the sections were incubated with rhodamine-conjugated
goat anti-mouse antibody (dilution 1:100; Sigma-Aldrich) orThe American Journal of Pathology - ajp.amjpathol.orgdonkey anti-goat antibody (dilution 1:100; Millipore), or goat
ﬂuorescein isothiocyanateeconjugated anti-mouse antibody
(dilution 1:100; Sigma-Aldrich) for 1 hour. Staining speci-
ﬁcity was conﬁrmed by substituting isotype IgG antibody for
the primary antibody. Finally, the sections were washed 3 in
PBS, stained with DAPI diluted 1:5 105 in double-distilled
H2O (Sigma-Aldrich), and mounted in a non-fade mounting
medium (Life Sciences International, Basingstoke, UK).
Immunoﬂuorescence was assessed at 400 with a Zeiss
microscope (Carl Zeiss Vision, München-Hallbergmoos,
Germany) equipped with a cooled charge-coupled device
camera (AxioCam HR; Carl Zeiss Microimaging, Jena,
Germany). No cross-reaction was found among these anti-
bodies. Five randomly selected ﬁelds from each section (three
sections/tissue) from third trimester deciduae were examined.
The number of cells per ﬁeld (106 pixel2) was counted and
calculated as the mean of 15 ﬁelds. All of the sections were
evaluated by two individuals blinded to the diagnosis.
Functional pNK Cell Studies
Circulating NK cells were isolated from healthy donors
using the human NK Cell Isolation Kit (130-092-657;
Miltenyi Biotec, Bergisch Gladbach, Germany) and incu-
bated at 5  105 cells/mL in BM containing IP-10 or I-TAC
or both at a ﬁnal concentration of 0.1, 1, 10, or 50 ng/mL
each as indicated. After 48 hours incubation at 37C and 5%
CO2, cells were collected followed by immunoﬂuorescence
staining and ﬂow cytometric analysis to assess purity and
CXCR3 expression. For the migration assay, 2  105 pNK
cells in 100 mL of BM were incubated with either IP-10 or
I-TAC or both at a ﬁnal concentration of 0.1, 1, 10, or 50
ng/mL for 48 hours and then loaded onto Transwell ﬁlters
(5-mm pore size, 24-well cell clusters; Corning, Corning,
NY). The ﬁlters were then placed in wells containing 600
mL of medium supplemented with IP-10 or I-TAC or both.
Although the pre-incubation was carried out at various
concentrations, the concentration of IP-10 or I-TAC or both
in the bottom chamber was 100 ng/mL. To determine
nonspeciﬁc migration, two wells without chemokine(s) were
used as controls. After 150 minutes incubation at 37C and
5% CO2, the upper chambers were removed, and cells in
the bottom chamber were collected and counted. The
percentage of migrated cells was calculated by subtracting
the value of spontaneously migrated cells from the number
of migrated cells at a given chemokine concentration, and
the result was divided by the total number of cells initially
loaded onto the Transwell ﬁlter.
Peripheral Blood IP-10 and I-TAC Concentrations in
Patients Developing Preeclampsia Versus Patients with
Uncomplicated Pregnancies
Serum samples from consenting pregnant women under-
going ﬁrst trimester aneuploidy screening were collected
under institutional review board approval at Mackay845
Table 1 Characteristics of Pregnant Women with Preeclampsia
and of Controls
Controls
(n Z 90)
Preeclampsia
(n Z 30) P value
Age, years 30.8  2.8 32.1  3.4 0.06
Parity 1.2  0.4 1.3  0.5 0.179
Gestational age of
delivery, weeks
38.7  1.1 37.7  2.2 0.001
Birth weight, g 3215.8  284.4 2755.5  658.5 <0.001
Gestational age of
sample collection,
weeks
12.5  0.5 12.4  0.4 0.402
Lockwood et alMemorial Hospital, Taiwan. Among women who eventually
gave birth at Mackay Memorial Hospital from April 2010 to
February 2011, 30 developed preeclampsia in the third
trimester. Preeclampsia was deﬁned according to standard
criteria.21 Gestational ageematched ﬁrst trimester control
(n Z 90) blood samples were obtained from women with
subsequent uneventful term deliveries. Gestational ages
did not differ signiﬁcantly between preeclamptic patients
(12.4  0.4 weeks) and controls (12.5  0.5 weeks) (P Z
0.402) (Table 1). Immunoreactive levels of IP-10 and
I-TAC in conditioned media were measured by commercial
ELISA kits according to the manufacturer’s instructions
(Duoset kits; R&D Systems).
Tissue ELISA Measurement of IP-10 and I-TAC
Concentrations in Preeclamptic Versus Gestational
Age-Matched Control Decidua
Frozen deciduae from patients with preeclampsia and
gestational ageematched controls were homogenized in
radioimmunoprecipitation assay lysis buffer (NP-40 2%,
SDS 0.02%, sodium deoxycholate 1%, 1 PBS) with
protease inhibitor cocktail (Sigma-Aldrich). Total protein
was measured using protein assay dye reagent (PAK500;
Strong Biotech, Taipei, Taiwan). Plates coated with 25 mg/
mL sample were incubated overnight at 25C, followed by
blocking for 1 hour with PBS containing 2% bovine serumFigure 1 Chemokine receptor expression by decidual and peripheral NK c
ﬂuorescence-conjugated monoclonal antibodies reactive with CD3, CD16, CD56, t
antibodies. Initially, cells were gated by forward scatter/side scatter characterist
CD3 cells. A: Representative histograms of chemokine receptor expression in N
black curve. CD56brightCD16 dNK cells, minority CD56brightCD16 pNK cells, and m
of chemokine receptor expression in NK cell from three donors.
846albumin. Subsequently, anti-human IP-10 or I-TAC
(1 mg/mL; R&D Systems) antibody was added and incu-
bated for 1 hour. The plates were incubated with horseradish
peroxidaseeconjugated secondary antibody (dilution
1:5000; Chemicon/Millipore) for 1 hour, then incubated
with NeA-Blue (Clinical, Mansﬁeld, MA) for 1 hour. The
reaction was stopped by 2N H2SO4. Relative chemokine
levels were expressed as absorbance.
Statistical Analysis
For ELISA and RT-qPCR IP-10 and I-TAC data from
decidual cell cultures, nonparametric tests were used because
data were not distributed normally. Comparisons of control
and treatment groups used the Kruskal-Wallis analysis of
variance on ranks test followed by the Student-Newman-
Keuls post hoc test with a P value <0.05 representing
statistical signiﬁcance. Student’s t-tests were used for all
pNK cell data, with P values <0.01 representing statistical
signiﬁcance. For both serum and tissue ELISA data and
ﬂuorescent immunohistochemistry data from preeclamptic
versus control patients, the Student’s t-test was used, with a
P value <0.05 representing statistical signiﬁcance.
Results
Flow Cytometric Analysis of NK Cell Chemokine
Receptors
Figure 1A displays representative histograms for the expres-
sion of six chemokine receptors (CCR1, CCR7, CCR9,
CXCR1, CXCR3, and CXCR4) obtained by gating on
CD56brightCD16 dNKcells or on either CD56brightCD16 or
CD56dimCD16þ pNK cells. Comparison of mean ﬂuores-
cence intensities in Figure 1B indicates that compared
with the CD56dimCD16þ population of pNK cells,
CD56brightCD16 dNK cells express relatively higher levels
of CXCR3, CCR9, CCR1, and CXCR4. Of these chemokine
receptors, CXCR3 is also highly expressed on minority
circulating CD56brightCD16 pNK cells. In this subset,
CXCR3 is expressed at higher levels than CCR7, and much0
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ics. CD56 and CD16 expression were each analyzed after setting a gate on
K cells. Isotype: ﬁlled gray curve; anti-chemokine receptor antibody: solid
ajority CD56dimCD16þ pNK cells. B: Mean ﬂuorescence intensity (MFI)  SD
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Table 2 Microarray Results for IP-10 and I-TAC mRNA in First
Trimester Decidual Cells
First trimester Fold change
Chemokine
Cognate
receptor
Alternate
name
EM vs
EMI
EM vs
EMTNF
CXCL10 CXCR3 IP-10 239.33 174.86
CXCL11 CXCR3 I-TAC 154.34 58.65
Leukocyte-free ﬁrst trimester decidual cells were primed in E2 þ MPA
(Control) and then switched to deﬁned medium with E2 þ MPA 10 ng/mL
IL-1b (EMI) or TNF-a (EMTNF) for 6 hours. mRNA levels were measured by
microarray. Results are shown as fold-change versus control.
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Figure 2 Concentration-dependent effects of TNF-a or IL-1b or IP-10
and I-TAC protein levels in cultured ﬁrst trimester decidual cells.
Leukocyte-free ﬁrst trimester decidual cells were primed in E2 þ MPA then
switched to a deﬁned medium with E2 þ MPA  IL-1b (asterisk) or TNF-
a (black circle) or IFN-g (black triangle) at the concentrations indicated on
the abscissa for 24 hours. Levels of IP-10 (A) and I-TAC (B) were measured
by ELISA in conditioned medium supernatants and normalized to total cell
protein (see Materials and Methods for details) (average of two separate
experiments).
Decidual Cells Recruit Decidual NK Cellshigher than CXCR4, CCR1, CCR9, and CXCR1. On the
majority circulating CD56dimCD16þ pNK cells, only
CXCR1, a receptor for IL-8, is highly expressed, whereas
CCR7 and CXCR3 are expressed at low-to-intermediate
levels, and CCR1 and CXCR4 at low levels (Figure 1B). By
indicating that both decidual and peripheral CD56bright
CD16 NK cell subsets express signiﬁcantly elevated levels
of CXCR3, Figure 1 suggests a potential role for CXCR3 in
mediating preferential trafﬁcking of circulating CD56bright
CD16 NK cells to the decidua, thereby explaining the
unusual abundance of these cells at this site.
Effects of TNF-a, IL-1b, and IFN-g on First Trimester
Decidual Cell IP-10 and I-TAC Expression
The microarray screening results displayed in Table 2
indicate that in cultured ﬁrst trimester decidual cells incu-
bated with E2 þ MPA, to mimic the hormonal milieu of
early pregnancy, addition of either TNF-a or IL-1b signif-
icantly up-regulates steady-state levels of mRNAs for the
cognate CXCR3 ligands, IP-10, and I-TAC. Figure 2
displays the effects of incubating ﬁrst trimester leukocyte-
free decidual cell monolayers over a physiological range
of concentrations up to 10 ng/mL TNF-a or IL-1b or IFN-g
on secreted levels of immunoreactive IP-10 (Figure 2A) and
I-TAC (Figure 2B). The responses are linear over the entire
concentration range for TNF-a and IFN-g, but attain
a maximum effect at 1.0 ng/mL for IL-1b.
The individual effects of 1.0 ng/mL each of TNF-a or IL-
1b or IFN-g and the combined effects of IFN-g with either
TNF-a or IL-1b on mRNA expression are displayed for IP-
10 (Figure 3A) and for I-TAC (Figure 3B). For IP-10
mRNA levels (mean  SEM): IFN-g, TNF-a, and IL-1b
produced increases over basal output of 922  430-fold,
581  381-fold, and 508  219-fold, respectively. For
I-TAC mRNA levels (mean  SEM): IFN-g, TNF-a, and
IL-1b produced increases over basal output of 897  508-
fold, 202  97-fold, and 131  64-fold, respectively. The
combination of IFN-g with TNF-a or IL-1b resulted in IP-
10 mRNA levels of more than 40,000-fold greater than
basal output and about 30-fold greater than the sum of each
cytokine used alone. For I-TAC, the combination of IFN-g
with TNF-a or IL-1b results in mRNA expression levelsThe American Journal of Pathology - ajp.amjpathol.orgthat are about 36,000-fold greater than basal output, and
about 40-fold greater when each cytokine was used alone.
Figure 3 also displays the individual effects of 1.0 ng/mL
TNF-a or IL-1b or IFN-g and the combined effects of
IFN-g with either TNF-a or IL-1b on secreted IP-10
(Figure 3C) and I-TAC (Figure 3D) concentrations. For
IP-10 levels (mean  SEM): IFN-g stimulation induces
3.20  0.84 pg/mL/mg protein, an increase of 468  179-
fold over basal output (0.012  0.003 pg/mL/mg protein);
TNF-a induces 3.22  1.22 pg/mL/mg protein, an increase
of 356  115-fold over basal output; and IL-1b induces
2.26  1.02 pg/mL/mg protein, an increase of 256  104-
fold over basal output. For I-TAC (mean  SEM): IFN-g
induces 0.45  0.16 pg/mL/mg protein, an increase of 278 
120-fold over basal output (0.002  0.0003 pg/mL/mg
protein); TNF-a induces 0.32  0.13 pg/mL/mg protein, an
increase of 179  64-fold over basal output; and IL-1b
induces 0.10  0.06 pg/mL/mg protein, an increase of 52 
29-fold over basal output. Note that basal and induced levels
of IP-10 are approximately 5 to 10 times greater than the
corresponding levels for I-TAC. Co-incubation of IFN-g
with either TNF-a or IL-1b produced striking synergistic847
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Figure 3 Separate and interactive effects of
TNF-a or IL-1b or IFN-g on IP-10 and I-TAC
protein and mRNA expression in cultured ﬁrst
trimester decidual cells. Leukocyte-free ﬁrst
trimester decidual cells were primed in E2 þ MPA
(CON). Cultures were then switched to deﬁned
medium (DM) with the steroids and either IL-1b or
TNF-a or IFN-g or TNF-a þ IFN-g or IL-1bþ IFN-g
for 6 hours for mRNA or 24 hours for protein
analysis. The mRNA levels for IP-10 (A) and I-TAC
(B) were measured by RT-qPCR on RNA extracts
and normalized to b-actin, a reference gene (nZ
8, mean  SEM). Protein levels of IP-10 (C) and
I-TAC (D) were measured by ELISA in conditioned
medium supernatants and normalized to total cell
protein (nZ 10, mean  SEM). See Materials and
Methods for details. *P < 0.05 versus CON; yP <
0.05 versus TNF-a alone; zP < 0.05 versus IL-1b
alone. Western blotting (E) was carried out for
IP-10 and I-TAC on 24 hours conditioned medium.
Recombinant human IP-10 or I-TAC (2.5 ng per
lane) are shown as positive controls (Pos) (see
Materials and Methods for details).
Lockwood et alaugmentation of IP-10 and I-TAC outputs. Combinations
of IFN-g with TNF-a or IL-1b produced IP-10 levels of
190.1  32.7 and 158.8  25.3 pg/mL/mg protein, respec-
tively. These represent increases of about 24,000-fold over
basal output, and 35-fold greater than the levels induced by
each cytokine added individually. In parallel measurements
for I-TAC, IFN-g added with TNF-a or IL-1b produces levels
of 38.0  4.9 and 23.5  5.1 pg/mL/mg protein, respectively,
which represent a >14,000-fold increase over basal output
and an 80-fold increase over each cytokine used alone.
The Western blots depicted in Figure 3E conﬁrm the
ELISA results for IP-10 (Figure 3C) and for I-TAC
(Figure 3D). Speciﬁcally, the antibodies used recognize
individual bands in the decidual celleconditioned medium
that migrate with the mobility of IP-10 (8.5 kDa) and I-TAC
(8.3 kDa). Compared with the corresponding control incu-
bation, the magnitude of each band is modestly augmented
during incubation with TNF-a or IL-1b or IFN-g, with
marked synergistic augmentation evident in co-incubations
with IFN-g plus TNF-a or IL-1b.
Effects of TNF-a, IL-1b, and IFN-g on First Trimester
Decidual Cell MCP-1, IL-6, IL-8, and IL-11 Expression
As shown in Figure 4, both TNF-a, and IL-1b signiﬁcantly
increased secreted levels of each of the evaluated848chemokines. Speciﬁcally, for MCP-1 compared with basal
output of 4.7  1.6 pg/mL/mg cell protein (mean  SEM),
TNF-a elicits a 48.9  13.5-fold increase and IL-1b elicits
a 79.6  15.5-fold increase (mean  SEM), respectively
(Figure 4A). Figure 4B indicates basal IL-6 production of
0.06  0.02 pg/mL/mg cell protein, with TNF-a eliciting
a 32.5  5.1-fold increase and IL-1b eliciting a 2871  994-
fold increase, respectively. Figure 4C shows basal IL-11
output of 0.08  0.02 pg/mL/mg cell protein, with TNF-a
eliciting a 7.4  2.1-fold increase and IL-1b eliciting
a 618.9  309.6-fold increase, respectively. Figure 4D
shows basal IL-8 output of 0.50  0.15 pg/mL/mg cell
protein, with TNF-a eliciting a 547.0  116.2-fold increase
and IL-1b eliciting a 2850  385-fold increase (mean 
SEM), respectively. Unlike the marked responses to TNF-a
and IL-1b, IFN-g is either ineffective or much less effective
at elevating secreted levels of each chemokine. Only for
MCP-1 did IFN-g up-regulation achieve statistical signiﬁ-
cance (5.9  1.5-fold increase, mean  SEM, P < 0.05).
Moreover, in contrast to the striking synergistic increases in
secreted levels of IP-10 and I-TAC displayed in Figure 3, C
and D, during co-incubation of IFN-g with either TNF-a or
IL-1b, Figure 4 indicates that co-incubation of IFN-g with
either cytokine produces less than additive effects for MCP-
1 (Figure 4A), IL-6 (Figure 4B), and IL-8 (Figure 4D), and
a subtractive effect for IL-11 (Figure 4C).ajp.amjpathol.org - The American Journal of Pathology
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Figure 4 Separate and interactive effects of
TNF-a or IL-1b or IFN-g on monocyte, neutrophil,
and NK cell recruiting chemokine expression
by ﬁrst trimester decidual cell monolayers.
Leukocyte-free ﬁrst trimester decidual cells were
primed in E2 þ MPA [control (CON)]. Cultures
were then switched to deﬁned medium with the
steroids and either IL-1b or TNF-a or IFN-g or TNF-
a þ IFN-g or IL-1bþ IFN-g for 24 hours. Levels of
MCP-1 (A), IL-6 (B), IL-11 (C), and IL-8 (D)
measured by ELISA in conditioned medium
supernatants and normalized to total cell protein
(see Materials and Methods for details) (n Z 8,
mean  SEM). *P < 0.05 versus CON; yP < 0.05
versus IFN-g alone; zP < 0.05 versus TNF-a alone;
and xP < 0.05 versus IL-1b alone.
Decidual Cells Recruit Decidual NK CellsEffects of Knockdown of IFN-gR1 and -R2 mRNA on
IP-10 and I-TAC mRNA Expression
As shown in Figure 5A, 92% knockdown of IFN-gR1
mRNA was obtained 48 hours after siR1 transfection versus
control siRNA. Importantly, the siR1 does not affect the
nontargeted b-actin mRNA, conﬁrming the speciﬁcity of the
IFN-gR1 knockdown. Similarly, transfection of siR2 leads
to a 95% down-regulation of IFN-gR2 (Figure 5B).
Furthermore, the combination of siR1 and siR2 (double
knockdown) elicits an w90% knockdown efﬁciency with
each gene (Figure 5C). Consistent with the RT-qPCR results
shown in Figure 3, A and B, results obtained with controlThe American Journal of Pathology - ajp.amjpathol.orgsiRNA indicate that IFN-g induces higher mRNA levels for
IP-10 (Figure 5D) and I-TAC (Figure 5E) than TNF-a added
alone and that co-incubation with TNF-a plus IFN-g syner-
gistically enhances both IP-10 and I-TAC. Individual siRNA-
mediated knockdown of IFN-gR1 and -R2 neutralizes
augmentation of IP-10 (Figure 5D) and I-TAC (Figure 5E)
elicited by IFN-g, but only marginally inhibits TNF-ae
induced IP-10 and I-TAC mRNA levels. In co-incubation
with TNF-a plus IFN-g, siRNA-mediated knockdown of
IFN-gR1 is more effective than IFN-gR2 in blocking syner-
gistic up-regulation of IP-10 and I-TAC. Simultaneous
silencing of both receptors eliminates the synergistic up-
regulation of both IP-10 and I-TAC (Figure 5, D and E).Figure 5 Effects of siRNA-mediated knockdown
of IFN-gR1 and IP-10, I-TAC, IFN-gR1, and IFN-gR2
mRNA expression. AeC: Gene knockdown of human
IFN-gR1, or IFN-gR2, or both. Levels of b-actin are
shown as a nontargeted negative control. A: Single
IFN-gR1 gene knockdown. Cells were transfected
with control siRNA (siCon) or siR1, and the levels of
IFN-gR1mRNAs are shown on the ordinate.B: Single
IFN-gR2 gene knockdown. Cells were transfected
with siCon or siR2, and the levels of IFN-gR2mRNAs
are shown on the ordinate. C: Double knockdown of
IFN-gR1 and IFN-gR2. Cells were transfected with
siCon, or a combination of siR1 and siR2, and the
levels of IFN-gR1 and IFN-gR2 mRNAs are shown.
The levels of the indicated mRNAs from siCon-
transfected cells were arbitrarily set as 1. Error
bars indicate mean  SD (nZ 3). D and E: Human
leukocyte-free ﬁrst trimester decidual cells were
transfected with siRNAs speciﬁc for siR1, siR2, or
siCon for 24 hours and then incubated with either 1
ng/mL TNF-a or IFN-g or both for 6 hours (nZ 1).
Levels of mRNA were measured using real-time and
RT-qPCR for IP-10 (D) and I-TAC (E).
849
Figure 6 Immunostaining for IP-10, I-TAC, IFN-gR1, and IFN-gR2 in ﬁrst trimester decidua. Serial cryosections of ﬁrst trimester decidua were immu-
nostained with IP-10 (A and B) or I-TAC (D and E) (green ﬂuorescence) and then with either the decidual cell marker vimentin (A and D) or the EVT marker
cytokeratin 7 (CK7) (B and E) (red ﬂuorescence). Sections were also immunostained for vimentin (red) and either IFN-gR1 (C) or IFN-gR2 (F) (green). DAPI
(blue ﬂuorescence) denotes nuclear immunostaining. Overlap between red and green immunostaining is seen as yellow or orange. Arrows indicate coloc-
alization of IP-10 in vimentin-positive decidual cells (A) and indicate CK7-positive EVT cells expressing IP-10 (B). Arrowheads indicate decidual cells
expressing I-TAC (D) and EVTs expressing I-TAC (E). Original magniﬁcation of representative sections, 400.
Lockwood et alImmunostaining of IP-10, I-TAC, IFN-gR1, and -R2 in
First Trimester Human Decidua
Cryosections of ﬁrst trimester deciduae were sequentially
immunostained for either IP-10 (Figure 6, A and B) or I-
TAC (Figure 6, D and E) and then with either vimentin as
a decidual cell marker (Figure 6, A and D) or CK7 as an
EVT marker (Figure 6, B and E). The sections were also
stained for DAPI to identify nuclei. Overlap between red
and green immunostaining appears as yellow-to-orange
staining. For IP-10, inspection of Figure 6A indicates that
the overwhelming majority of cells demonstrate colocali-
zation of IP-10 in vimentin-positive decidual cells, evident
by the resulting yellow-orange staining. The pure green
staining in the majority of the cells in Figure 6B indicates
that cells expressing IP-10 are mainly non-EVT. Figure 6B
indicates that only a few CK7-positive EVT cells express
IP-10. Inspection of Figure 6D indicates that virtually all of
the decidual cells also express I-TAC, albeit at lower
intensity than IP-10. As with IP-10, very few EVTs express
I-TAC as seen in Figure 6E. These in situ ﬁndings are
consistent with the higher levels of basal IP-10 than I-TAC
mRNA (Figure 3, A and B) and secreted protein (Figure 3,
C and D) measured in cultured decidual cells. Cryosections
were also immunostained for IFN-gR1 or -R2 and then
vimentin. Positive staining for IFN-gR1 (Figure 6C) and
-R2 (Figure 6F) was primarily localized to decidual cells,
with blue staining denoting nuclei.850Signaling Pathway Mediation of Synergistic
Enhancement of IP-10 and I-TAC Expression
Figure 7 demonstrates that TNF-a þ IFN-g signiﬁcantly
enhances IP-10 (Figure 7A) and I-TAC (Figure 7B)
expression compared with control or TNF-a alone or IFN-g
alone. Pretreatment of cultured decidual cells with either
BAY (NFkB inhibitor) or MTA (JAK/STAT inhibitor)
alone or in combination blocks the synergistic effects of
TNF-a þ IFN-g on IP-10 or I-TAC expression.
The E-EMSA analysis displayed in Figure 7C shows that
nuclear extracts obtained from decidual cells treated with
TNF-a alone or IFN-g alone exhibit higher binding of
NFkB subunits p65 and p50 to NFkB-RE compared with
control. This binding to NFkB-RE increased further in
nuclear extracts from decidual cells treated with TNF-a þ
IFN-g. Moreover, pretreatment of decidual cells with either
BAY or MTA alone or with BAY þ MTA for 1 hour
signiﬁcantly reduced NFkB-RE binding of p65 and p50 in
nuclear extracts compared with decidual cells treated with
TNF-a þ IFN-g (Figure 7C).
The Effects of IP-10 and I-TAC on CXCR3 Expression by
and Migration of pNK Cells
Figure 8 demonstrates the effects of incubating CD56bright
CD16 or CD56dimCD16þ pNK cells with IP-10 or I-TAC
on CXCR3 expression. Incubation of both NK cell subsetsajp.amjpathol.org - The American Journal of Pathology
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Figure 7 Signaling pathway mediation of IP-10 and I-TAC expression. A: IP-10 and B: I-TAC secretion by decidual cells treated with vehicle, TNF-a, IFN-g,
and TNF-a þ IFN-g with or without NFkB inhibitor BAY, or JAT/STAT inhibitor (MTA) or BAY þ MTA (n Z 3, mean  SEM). *P < 0.05, **P < 0.01, and
***P < 0.005. (C) Representative binding of decidual cellederived nuclear NFkB subunits p65 and p50 to NFkB-RE by E-EMSA (n Z 2).
Decidual Cells Recruit Decidual NK Cellswith either IP-10 (Figure 8A) or I-TAC (Figure 8B) elicits
a concentration-dependent increase in CXCR3 that peaks
at 10 ng/mL. However, either 50 ng/mL IP-10 or I-TAC
down-regulates CXCR3 expression. Figure 8C demonstrates
that the combination of equal concentrations of IP-10 and
I-TAC elicits a similar concentration-dependent biphasic
effect on CXCR3 expression. Parallel concentration-
dependent biphasic effects are also observed on the migra-
tion of both pNK cell subtypes (Figure 9). Thus, either IP-10
(Figure 9A) or I-TAC (Figure 9B) or the combination of
IP-10 and I-TAC (Figure 9C) progressively enhances cell
migration at concentrations of 0.1 to 10 ng/mL, whereas
50 ng/mL impedes migration. Importantly, the biphasic
effects observed are donor-independent.
CD56brightCD16 NK Cells in Preeclamptic Decidua
Decidual sections from women with preeclampsia versus
gestational ageematched control specimens were immuno-
stained sequentially for CD56 (green ﬂuorescence) and
CD16 (red ﬂuorescence). The absence of CD16 and the0.0
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Figure 8 Effects of IP-10 and I-TAC on CXCR3 expression by pNK cells. The lym
density gradient centrifugation, followed by puriﬁcation of pNK cells using NK cell
were incubated with 0, 0.1, 1, 10, or 50 ng/mL IP-10 (A) or I-TAC (B) or IP-10 plus
gated CD56þCD3 NK cells. Data are presented as means  SEM (n Z 7), with
arbitrarily set as 1. The bar groups represent CD56dimCD16þ and CD56brightCD16 su
10 and I-TAC, by Student’s t-test.
The American Journal of Pathology - ajp.amjpathol.orgpresence of strong staining for CD56 in control and
preeclamptic specimens indicate that virtually all NK cells
in decidua are CD56brightCD16. The more abundant green
staining in Figure 10A compared with Figure 10B suggests
that preeclamptic decidua contains fewer CD56brightCD16
NK cells. As indicated in Figure 10C, lower NK cell
numbers in preeclamptic versus gestational ageematched
control decidua attained statistical signiﬁcance.Measurement of IP-10 and I-TAC Levels in First
Trimester Sera and Term Deciduae of Patients With and
Without Subsequent Preeclampsia
In Figure 11A, a statistically signiﬁcant increase in IP-10
levels in ﬁrst trimester serum predicts later development of
preeclampsia. By contrast, no such correlation was observed
for the serum levels of I-TAC (Figure 11B). Tissue ELISA
analyses for decidual extracts frompatientswith preeclampsia
ﬁnd signiﬁcantly higher levels of IP-10 (Figure 11C) and
I-TAC (Figure 11D) than age-matched controls.CD56 CD16
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Lockwood et alDiscussion
In NK celledeﬁcient mice, the decidual vasculature lacks
characteristic mid-gestation dilation, elongation, and loss of
smooth muscle associated with increased blood ﬂow, similar
to lesions seen in human preeclampsia.22 These effects are
ameliorated by treatment with mouse IFN-g or with the
IFN-geregulated cytokine-binding protein, a-2 macro-
globulin, which enhances decidual remodeling and produces
normal histological changes in decidual blood vessels.23
Ninety percent of mouse uterine IFN-g is dNK celle
derived, indicating that IFN-g is necessary and sufﬁcient to
mediate normal uterine vascular remodeling in pregnant
mice.24 Close proximity between dNK cells and blood
vessels suggests that dNK cellederived angiogenic factors
may augment the effects of IFN-g to promote normal
vascular remodeling.25 Extrapolation of studies in NK
celledepleted mice to humans26,27 suggests that the minorityFigure 10 CD56brightCD16 NK cells in preeclamptic (PE) versus control
(CON) decidua. Decidua from patients with preeclampsia (A) and gesta-
tional ageematched controls (B) were stained with anti-human CD56
(green) and CD16 (red) antibodies. Arrows indicate CD56brightCD16 cells.
Representative slides from eight independent experiments are shown.
Original magniﬁcation, 400. C: Comparison of CD56brightCD16 cells
between preeclamptic and control decidua. Results are presented as mean
 SEM (n Z 8) of the CD56brightCD16 cells. ***P < 0.001.
852CD56brightCD16 pNK cells trafﬁc from the circulation to
the decidua in early pregnancy.
Transformation of spiral arteries and arterioles into high-
capacity vessels with markedly increased uteroplacental
blood ﬂow to the developing fetaleplacental unit has
been attributed to replacement of vascular smooth muscle
and endothelial cells by ﬁbrinoid-embedded endovascular
EVTs.28 Spiral arterial lining endovascular EVTs express
stromal cellederived factor-1 (SDF-1) (alias CXCL12),
which binds to CCR4-expressing CD56brightCD16 pNK
cells to mediate their recruitment to the decidua.28 In these
specimens, inﬁltrating dNK cells and macrophages were
identiﬁed in the vascular smooth muscle layers accompanied
by the appearance of apoptotic markers in vascular smooth
muscle and endothelial cells. This induction of apoptosis was
attributed to dNK celle and macrophage-expressed matrix
metalloproteinase (MMP)-7 andMMP-9.29 Such trophoblast-
independent decidualization-associated vascular remodeling
is also indicated by early signs of vascular transformation
in decidua from ectopic tubal pregnancies or in late luteal
phase nonpregnant endometrium.30,31 In the early pregnant
golden hamster, dNK cells invade the vascular wall before
trophoblast invasion and are implicated in directly mediating
endometrial vascular remodeling.32
The origin of dNK cells in humans is alternatively ascribed
to: i) differentiation of resident endometrial NK cells7,11; ii)
self-renewal from local progenitor stem cells33; and iii)
trafﬁcking of pNK cells.34 In support of the last, the majority
circulating CD56dimCD16þ pNK cells were shown to be
recruited to the decidua, then differentiate into CD56bright
CD16 NK cells by decidual cellederived transforming
growth factor-b.35,36 However, abundant evidence points to
the minority circulating CD56brightCD16 pNK cells as the
major contributors to the dNK cell population. Their pref-
erential recruitment is suggested by elevated expression of
L-selectin, which mediates interactions with vascular endo-
thelium37 by CD56brightCD16 pNK cells, but not by
CD56dimCD16þ pNK cells. Moreover, the current study
conﬁrms that CD56brightCD16 pNK cells express high
levels of CXCR314 (Figure 1, A and B), a receptor for
decidual cellederived IP-10 and I-TAC that canajp.amjpathol.org - The American Journal of Pathology
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Figure 11 Comparison of immunoreactive IP-10 and I-TAC expression
in serum from ﬁrst trimester of controls (CON) versus patients subsequently
developing preeclampsia (PE) and decidual tissues from preeclampsia
versus gestational age-match third trimester decidua. IP-10 (A) and I-TAC
(B) levels in serum obtained from ﬁrst trimester gestation measured by
ELISAs. Results are presented as mean  SEM (n Z 30 for preeclampsia,
nZ 90 for control) of IP-10 and I-TAC serum levels. *P < 0.05. IP-10 (C)
and I-TAC (D) levels in deciduae obtained from patients with and without
preeclampsia measured by ELISAs. Results are presented as means  SEM
(n Z 7). *P < 0.05.
Decidual Cells Recruit Decidual NK Cellspreferentially promote trafﬁcking to the decidua. Recently,
IP-10 secreted by various human endometrial, but not NK
cells, was shown to chemoattract blastocyst-derived CXCR3-
expressing trophectoderm.38
Human maternalefetal interactions create a mild systemic
inﬂammatory state initiated in the luteal phase of the
menstrual cycle characterized by vascular endothelial activa-
tion, leukocytosis, increased monocyte activity, and elevated
circulating chemokine and cytokine levels that become most
apparent in the third trimester of uncomplicated human
pregnancies.39 Decidual cellemediated recruitment of NK
cells in normal pregnancy is indicated by a report that
progesterone enhances mRNA expression of NK cell-
recruiting chemokines, ie, fractalkine (alias CX3CL1) and
MCP-1 (alias CCL2), aswell as IP-10 in primaryﬁrst trimester
human decidual cells, and NK cell migration is enhanced by
using these decidual cells cultured with progesterone as
a substrate.40 Extending these observations to bettermimic the
decidual milieu of pregnancy, the current study used E2 þ
MPA to maintain decidualization of leukocyte-free ﬁrst
trimester decidual cell monolayers in combination with
proinﬂammatory cytokines IFN-g, a primary NK cell product,
and/or TNF-a or IL-1b, primary macrophage products. The
resulting marked synergistic increase in IP-10 and I-TAC
mRNA and protein expression suggests that decidual
cellemediated crosstalk between NK cells and macrophages
leads to preferential recruitment and retention of additional
CDbrightCD16e NK cells to the decidua.28The American Journal of Pathology - ajp.amjpathol.orgPreviously, expression proﬁling of several genes revealed
striking differences between the minority peripheral versus
decidual CD56brightCD16 NK cell populations, suggesting
that dNK cells represent a unique NK cell subset.17 Evidence
that the decidual milieu induces differentiation of recruited
CD56brightCD16 NK cells is provided by observations that
incubation of peripheral CD56brightCD16 NK cells with
decidual cellederived cytokines, particularly IL-15, induces
a chemokine receptor repertoire similar to that expressed by
dNK cells.28 Progestins and NK cellederived IFN-g enhance
decidual cell IL-15 production.41 These observations
complement a report that dNK cells express the IL-2
receptor,42 which mediates IL-15 activation of NK cells.43
Like the majority CD56dimCD16þ pNK cells, dNK cells
express KIRs and display granules containing cytolytic
molecules, such as perforin and granzymes A and B.17
However, dNK cells exhibit markedly reduced cytotoxicity
compared with the majority CD56dimCD16þ pNK cells and
are even less cytotoxic than the relatively nontoxic minority
CD56brightCD16 pNK cells.11,44 Although dNK cells form
conjugates and activating immune synapses with target cells,
their failure to polarize their microtubule organizing centers
and transport perforin-containing granules to the synapse
impedes cytotoxicity.44
Paradoxically, dNK cells express multiple pregnancy-
promoting factors. Like the minority circulating CD56bright
CD16 pNK cells, dNK cells produce growth factors, such as
GM-CSF, leukemia inhibitory factor, TNF-a, and IFN-
g.7,17,45e47 In addition, dNK cells express EVT invasion-
enhancing IL-8 and IP-10, as well as angiogenic factors,
such as vascular endothelial growth factor, placental-derived
growth factor, angiopoietin 2, and NKG5.7,45,46 Taken
together, these observations indicate that human dNK cells
differ phenotypically from both pNK cells and NK cells in
cycling endometrium to form a unique NK cell subtype that
supports normal pregnancy by promoting trophoblast inva-
sion, vascular remodeling, and in view of their lack of cyo-
totoxicity, immune tolerance of the fetal semiallograft.
The current study employs a multitiered approach to
reveal that targeting of ﬁrst trimester human decidual cells48
by paracrine effectors released by the predominant decidual
immune cell types, dNK cells and macrophages, recruits
additional NK cells from the circulation. Initially, ﬂow
cytometric analysis demonstrated high expression of
CXCR3 on peripheral and decidual CD56brightCD16 NK
cells with lower CXCR3 levels on the majority circulating
CD56dimCD16þ pNK cells. Subsequently, incubation of
leukocyte-free ﬁrst trimester decidual cells with either of the
primary macrophage-derived cytokines, TNF-a or IL-1b,15
or primary dNK cellederived cytokine, IFN-g,12 markedly
elevated IP-10 and I-TAC mRNA and protein levels. Co-
incubation of IFN-g with either TNF-a or IL-1b produced
striking synergistic increases in IP-10 and I-TAC mRNA
and protein levels far exceeding the sum of the individual
responses. In parallel incubations, expression of other
monocyte, neutrophil, and NK cell chemoattractants and/or853
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Figure 12 Schematic representation of the contribution of JAK/STAT
and NFkB signaling pathways to TNF-a þ IP-10 and II-TAC secretion in ﬁrst
trimester decidual cells.
Lockwood et alactivators, ie, MCP-1, IL-6, -8, and -11 (Figure 4) were at
best additive, thereby emphasizing speciﬁcity of the syner-
gistic up-regulation of IP-10 and I-TAC expression in
human decidual cells. Consistent with in situ hybridization
observations for IP-10 and I-TAC,49 we observed prefer-
ential immunolocalization of IP-10 and I-TAC to vimentin-
positive decidual cells versus CK7-positive trophoblasts in
ﬁrst trimester decidual sections.
The individual and interactive contribution of IFN-g to
the marked synergistic enhancement of IP-10 and I-TAC
expression by ﬁrst trimester decidual cells revealed by the
current study provides strong evidence that IFN-g is
involved in CD56brightCD16 cell recruitment to the
decidua. Two receptors, IFN-gR1 and IFN-gR2, mediate
IFN-g effects in target cells. Binding of cell membrane
expressed IFN-gR1 initiates IFN-gR1/R2 heterodimeriza-
tion, which mediates intracellular signaling.16 Use of
speciﬁc siRNAs to silence each receptor separately and
together neutralized the contribution of IFN-g, but did not
affect that of TNF-a to enhanced IP-10 and I-TAC mRNA
expression. In situ observations complementing in vitro
results provide the ﬁrst indication that at the implantation
site, immunoreactive IFN-gR1 and -R2 are preferentially
localized to vimentin-positive decidual cells (Figure 6).
Elucidation of the potential mechanisms underlying the
striking synergistic up-regulation of IP-10 and I-TAC
expression induced by TNF-a and IFN-g focused on NFkB
and JAK/STAT signaling pathways, which have been
shown to mediate cellular effects of TNF-a and IFN-g,
respectively.50,51 Pre-incubation of ﬁrst trimester decidual
cells with either BAY or MTA was sufﬁcient to block the
synergistic increase of TNF-a þ IFN-geinduced IP-10 and
I-TAC expression measured by ELISAs or E-EMSA
(Figure 7). Signaling pathway mediation of these effects is
depicted by the scheme in Figure 12. Speciﬁcally, it indi-
cates that binding of TNF-a to its receptor results in
dissociation of NFkB p65 and p50 subunits from NFkB
inhibitory molecule IkB, which is degraded by proteasomes.
The resulting p65 and p50 homo- and/or heterodimerization
is followed by translocation to the nucleus. The p65/p50
heterodimer then binds to NFkB-RE in the IP-10 and I-TAC
promoters. IFN-g activates the IFN-g receptor and its
downstream signaling JAK/STAT pathway. Activation of
JAK/STAT results in nuclear translocation of STAT where
it binds to its response element in the IP-10 and I-TAC
promoters. Because the JAK/STAT inhibitor MTA also
suppresses NFkB binding to NFkB-RE, IFN-g can also
activate further NFkB binding via the JAK/STAT pathway,
thereby contributing to synergistic up-regulation.
The current observations on primary human ﬁrst trimester
decidual cells and immunostaining of decidual sections are
complemented by parallel assessment of CXCR3 expression
and in vitro migration of CD56brightCD16 and CD56dim
CD16þ pNK cells during incubation with IP-10 or I-TAC or
both (Figures 8 and 9). Taken together, our ﬁndings have
translational implications for normal recruitment of both854pNK cell subsets to the decidua and aberrant pNK cell
trafﬁcking during preeclampsia. Speciﬁcally, incubation of
both pNK cell subsets with IP-10 and/or I-TAC elicits
concentration-dependent enhancement of CXCR3 expression
and NK cell migration that peaked at 10 ng/mL, with 50 ng/
mL inhibiting both endpoints. These observations suggest
that secreted IP-10 and I-TAC levels resulting from co-
stimulation of decidual cells by IFN-g with either TNF-a
or IL-1b cause the recruitment of additional NK cells to the
early decidua, but that overstimulation by these cytokines, as
would be observed in the inﬂammatory milieu of
preeclampsia, inhibits CXCR3 expression by, and in vitro
migration of, both pNK cell subsets. This would account for
the reduced number of NK cells observed in preeclamptic
decidua (Figure 10) and why elevated IP-10 levels in ﬁrst
trimester serum predict the subsequent development of
preeclampsia. Indeed, although elevated circulating levels of
angiogenesis mediators, endoglin and soluble fms-like tyro-
sine kinase receptor-1 (sFlt-1), in second or third trimester
serum52 also predict preeclampsia, IP-10 appears to be an
earlier indicator of risk. The importance of our observations
is highlighted by a recent review article53 that states
“Currently, no reliable markers exist to identify patients
before the development of symptoms. The early identiﬁca-
tion of women with risk of developing preeclampsia is crit-
ical, because careful monitoring and referral to a specialized
perinatal care center could substantially improve outcomes
for both the mother and fetus.”53,p957
The causes of preeclampsia-related decidual inﬂammation
are yet to be fully discerned. Placental oxidative and endo-
plasmic reticulum stress mediated by trophoblast-derived
growth factors, activin-A, corticotrophin-releasing hormone,
leptin, and placental microvesicles may play a role.54,55 Our
laboratory and others have observed excess dendritic cells
and macrophages in the preeclamptic decidua.56 Moreover,
we found that incubation of ﬁrst trimester decidual cells with
either IL-1b or TNF-a markedly enhances expression ofajp.amjpathol.org - The American Journal of Pathology
Decidual Cells Recruit Decidual NK Cellsseveral monocyte/macrophage-recruiting and -activating
cytokines19, and that activated macrophages treated with
conditioned medium obtained from ﬁrst trimester decidual
cells after incubation with IL-1b or TNF-a induce EVT
apoptosis and inhibit EVT invasiveness.51,57
Other studies evaluating the relationship between pre-
eclampsia and dNK cell numbers and phenotype have
produced conﬂicting results.58 However, as noted by Lash
and Bulmer,58 the lack of clarity among various studies as to
whether dNK cell numbers are reduced in preeclampsia and
intrauterine growth restriction likely reﬂects differences in
sampling, analysis, and severity of the disease. Beyond
altered dNK cell numbers, preeclampsia, as well as other
adverse pregnancy outcomes, such as fetal growth restric-
tion and recurrent miscarriage, are associated with mis-
matched KIR haplotype (KIR AA) expression by dNK cells
and EVTs.59
In summary, we postulate that enhanced periconceptional
decidual inﬂammation contributes to the genesis of shallow
placentation in preeclampsia by promoting excess decidual
cell IP-10 and I-TAC production, which blunts pNK cell
recruitment and leads to deﬁcient dNK cell numbers.
Coupled with excess decidual macrophages, these changes
impede EVT-mediated remodeling of spiral arteries, the
pathological sine qua non of preeclampsia.
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